GERALD HAMWI: Open Payments
NPI 1467447714 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 39 payments from 4 companies in 2025. Trend: 2023 $278 · 2024 $621 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 24 | $604 |
| Gilead Sciences, Inc. | 13 | $298 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Novo Nordisk Inc | 1 | $16 |
Products named: DOVATO, APRETUDE, CABENUVA, Biktarvy, SHINGRIX, Saxenda.
Industry payments across CA — which companies pay providers there.
